AC079602.1 | | | | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ANKRD22 | Ankyrin repeat domain 22 | | | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | | | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C10orf129 | Chromosome 10 open reading frame 129 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CAPN9 | Calpain 9 | Enzymes
| | | | | Tissue enhanced |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLIC6 | Chloride intracellular channel 6 | Transporters
| | | | | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COLCA1 | Colorectal cancer associated 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CRYBA2 | Crystallin, beta A2 | Disease related genes
| | | | | Tissue enhanced |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2S1 | Cytochrome P450, family 2, subfamily S, polypeptide 1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCHS2 | Dachsous cadherin-related 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
EPN3 | Epsin 3 | | | | | | Tissue enhanced |
FA2H | Fatty acid 2-hydroxylase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FAM177B | Family with sequence similarity 177, member B | | | | | | Tissue enhanced |
FAM83E | Family with sequence similarity 83, member E | | | | | | Tissue enhanced |
FER1L6 | Fer-1-like 6 (C. elegans) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
FOXA2 | Forkhead box A2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | Enzymes
| | | | | Tissue enhanced |
GALNT6 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes
| | | | | Tissue enhanced |
GIPR | Gastric inhibitory polypeptide receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GPR142 | G protein-coupled receptor 142 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HAP1 | Huntingtin-associated protein 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | | | | | | Tissue enhanced |
INSM1 | Insulinoma-associated 1 | Transcription factors
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | | | | | | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | | | | | | Tissue enhanced |
LIPH | Lipase, member H | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LL22NC03-75H12.2 | Novel protein; Uncharacterized protein | | | | | | Tissue enhanced |
MARCH4 | Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Tissue enhanced |